Ewha Womans University   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Seoul Korea, Republic of (1886)

Organization Overview

First Clinical Trial
2005
NCT00964769
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Ehwa Womans University Mokdong Hospital | Ehwa W. univ hospital | Ewah Womans University Medical Center | Ewha University Seoul Hospital | Ewha Womans University | Ewha Womans University College of Medicine | Ewha Womans University Dongdaemun Hospital | Ewha womans university hospital | Ewha Womans University Hospital | Ewha Womans University Medical Center of Korea | Ewha Womans University Mokdong | Ewha Womans University Mokdong Hospital | Ewha Womans University School of Medicine & Ewha Womans University Mokdong Hospital | Ewha Womans University Seoul hospital | Ewha Woman's University Seoul Hospital | Ewha Women's University Hospital | Ewha Women University Mokdong Hospital | Ewha W. University | I-wha Univ. | Iwha Womans Unversity | Iwha Womans Unversity Mokdong Hospital

Active Ingredients

Drugs in Phase 4 Trials (21)

23-valent pneumococcal polysaccharide vaccine (pneumovax-23) (1 trial)

acetylcysteine (mucomyst) (2 trials)

acetylsalicylic acid (aspirin) (1 trial)

bupropion (wellbutrin) (1 trial)

carbamazepine (tegretol) (1 trial)

clopidogrel (plavix) (2 trials)

escalitopram (Lexapro) (1 trial)

escitalopram (lexapro) (1 trial)

everolimus (zortress) (1 trial)

ezetimibe (zetia) (1 trial)

kremezin (1 trial)

lamotrigine (lamictal) (1 trial)

motilitone (1 trial)

multi-valent pneumococcal conjugate vaccine (1 trial)

naftopil (Flivas) (1 trial)

pantoprazole (protonix) (1 trial)

prasugrel (effient) (1 trial)

rosuvastatin (crestor) (1 trial)

sirolimus (rapamune) (2 trials)

ursodeoxycholic acid (2 trials)

valproic acid (depakene) (2 trials)

Drugs in Phase 3 Trials (23)

5,7-dihydroxy-3',4',6-trimethoxyflavone (1 trial)

ag npp709 (Synatura) (1 trial)

allogenic human chondrocytes expressing transforming growth factor-β1 (2 trials)

autologous culture chondrocytes (Carticel) (2 trials)

avanafil (stendra) (1 trial)

Biphenyl Dimethyl Dicarboxylate (1 trial)

blood plasma (1 trial)

entecavir (baraclude) (1 trial)

fimasartan (kanarb) (1 trial)

inactivated japanese encephalitis vaccine (Ixiaro) (1 trial)

levamlodipine (Conjupri) (1 trial)

levodropropizine (1 trial)

losartan (cozaar) (1 trial)

moxifloxacin (avelox) (1 trial)

progesterone (progestasert) (1 trial)

rebamipide (1 trial)

recoflavone (1 trial)

simvastatin (zocor) (1 trial)

sodium chloride (1 trial)

theobromine (1 trial)

udenafil (2 trials)

valsartan (diovan) (1 trial)

zabofloxacin (1 trial)

Drugs in Phase 2 Trials (13)

celecoxib (celebrex) (1 trial)

citicoline (1 trial)

cortisone acetate (cortone) (1 trial)

dienogest (natazia) (1 trial)

idarubicin (idamycin) (1 trial)

polmacoxib (1 trial)

quetiapine (seroquel) (1 trial)

rivaroxaban (xarelto) (1 trial)

tacrolimus (prograf) (1 trial)

thiamine (1 trial)

vitamin c (1 trial)

vm202 (1 trial)

warfarin (coumadin) (1 trial)

Drugs in Other Trials (13)

actinidia arguta (1 trial)

calcium carbonate (1 trial)

deer bone extract (1 trial)

fentanyl (Innovar) (2 trials)

fermented codonopsis lanceolata (1 trial)

hx106 (1 trial)

ketorolac (acuvail) (1 trial)

mulberry leaf extract (1 trial)

plantago ovata (1 trial)

polygonatum sibiricum (1 trial)

ropivacaine (naropin) (2 trials)

tremella fuciformis (1 trial)

vitamin d3 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acalculous Cholecystitis (Phase 3)

Acute Kidney Injury (Phase 3)

Arthritis (Phase 3)

Arthritis, Juvenile (Phase 3)

Arthritis, Psoriatic (Phase 3)

Atrial Fibrillation (Phase 2)

Bipolar Disorder (Phase 2)

Bronchitis (Phase 3)

Cerebral Infarction (Phase 2)

Cholecystitis (Phase 3)

Cholecystitis, Acute (Phase 3)

Coronary Artery Disease (Phase 4)

Crohn Disease (Phase 4)

Depression (Phase 4)

Depressive Disorder (Phase 4)

Depressive Disorder, Major (Phase 4)

Disease (Phase 2)

Dyspepsia (Phase 4)

Encephalitis (Phase 3)

Encephalitis, Japanese (Phase 3)

Endometriosis (Phase 2)

Epilepsy (Phase 4)

Erectile Dysfunction (Phase 3)

Essential Hypertension (Phase 3)

Gastritis (Phase 3)

Glomerulonephritis (Phase 3)

Heart Diseases (Phase 2)

Hepatitis (Phase 3)

Hepatitis B (Phase 3)

Hepatitis B, Chronic (Phase 3)

Hyperlipidemias (Phase 3)

Hyperlipoproteinemias (Phase 3)

Hyperplasia (Phase 4)

Hypertension (Phase 3)

Infarction (Phase 2)

Infections (Phase 3)

Ischemia (Phase 4)

Ischemic Attack, Transient (Phase 2)

Kidney Diseases (Phase 4)

Kidney Failure, Chronic (Phase 4)

Leukemia (Phase 2)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 2)

Leukemia, Myeloid (Phase 2)

Leukemia, Myeloid, Accelerated Phase (Phase 2)

Leukemia, Myeloid, Acute (Phase 2)

Leukemia, Myeloid, Chronic-Phase (Phase 2)

Lower Urinary Tract Symptoms (Phase 4)

Lung Diseases (Phase 3)

Lung Diseases, Obstructive (Phase 3)

Myelodysplastic Syndromes (Phase 2)

Myocardial Infarction (Phase 2)

Myocardial Ischemia (Phase 2)

Osteoarthritis (Phase 3)

Premature Birth (Phase 3)

Prostatic Hyperplasia (Phase 4)

Pulmonary Disease, Chronic Obstructive (Phase 3)

Renal Insufficiency (Phase 4)

Renal Insufficiency, Chronic (Phase 4)

Respiratory Tract Infections (Phase 3)

Spondylitis (Phase 3)

Spondylitis, Ankylosing (Phase 3)

Stress Disorders, Post-Traumatic (Phase 2)

Stress Disorders, Traumatic (Phase 2)

Stroke (Phase 4)

Substance-Related Disorders (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 56
  • # of Trial APIs: 70